FdaApplication
BLA 761133
Identifiers
- fda_app_no: BLA761133
Properties
| Property | Value |
|---|---|
| applicant_name | Takeda Pharmaceuticals U.S.A., Inc. |
| application_type | BLA |
| approval_date | 2023-09-27 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENTYVIO | VEDOLIZUMAB | 108MG/0.68ML | Injection |
| ENTYVIO PEN | VEDOLIZUMAB | 108MG/0.68ML | Injection |
2 products